Mylan sets sights on production of generic asthma inhaler – Tribune-Review


Yahoo News

Mylan sets sights on production of generic asthma inhaler
Tribune-Review
Besides providing a cheaper alternative for asthma sufferers across the country, being first to market with generic Advair is seen as key to Mylan's drive to boost growth and hit an ambitious earnings target of adjusted net income of at least $6 a
Mylan: Advair Generic Ready For LaunchBusiness Finance News

all 16 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.